0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Lyra Therapeutics Inc - Trending symbols

Latest News of Lyra Therapeutics Inc

DateTitleRead
2025-05-06
22:01
Lyra Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate UpdateRead



Trends

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Net Debt 4,52817,53322,061-17,2184,8436,68111,524-17,721-6,197
Long-term Assets Other 4,3533,1107,463-6,3521,111-428683-6830
Income Tax Expense -1,2301,017-213131-82-1,021-1,1031,11613
Reconciled Depreciation 286-7279-5722262284-307-23
Depreciation and Amortization 286-72791,2591,538-1,254284-307-23
Total Other Income Expense Net 3426608739331391,072-2,664-1,592
Gross Profit 2575,1105,367-4,960407-48359-1,352-993
Total Revenue 2575,1105,367-4,960407-48359-1,352-993

Comments

How you think about this?

Leave a comment

Stay informed about Lyra Therapeutics Inc.

Receive notifications about Lyra Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.